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Abstract
Background: We report an unusual case of infective colitis by Yersinia enterocolitica complicated by microliver abscesses
mimicking multiple liver metastases in a 79 yr old female without any risk factors for bacteriaemia by this pathogen.
Case presentation: The patient was admitted to the Internal Medicine with Stroke Care ward of University Policlinico “P.
Giaccone” in Palermo because of the appearance of diarrhoea. After the antimicrobial treatment for infective colitis, the
clinicians observed a persistently increased white blood cells (WBC) count and multiple hepatic lesions; after having
excluded any neoplastic disease and inflammatory bowel disease (IBD), blood cultures positive for Y. enterocolitica allowed
to establish the final diagnosis was infective micro liver abscesses consequent to infective colitis due to Y. enterocolitica,
which were successfully treated with cefixime and doxycycline.
Conclusions: This case report should make clinicians reflect on how complex the differential diagnosis between
microliver abscesses and metastasis could be and the possibility of bacteriaemia by Y. enterocolitica even without iron
overload conditions.
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Background
The presence of multiple hepatic lesions can represent a
challenge for clinicians. The differential diagnosis includes
mainly neoplastic disease, especially metastases, and liver
abscesses; consequently, it is necessary to examine both
possible etiologies in parallel. The investigation of the
possible presence of a neoplasm needs the use of imaging
techniques, such as magnetic resonance imaging (MRI) and
computed tomography (CT) scan; on the other hand, the
infective hypothesis requires blood cultures and stool test
to be confirmed. To establish the diagnosis, clinicians often
need to obtain a biopsy, but it is not always feasible because
of the smallness of the hepatic lesions or local expertise.
The typical symptomatology of liver abscesses re-
ported in the literature is characterized by right upper
abdominal pain, fever, jaundice and weight loss. Biliary
infections represent the most common cause of bacterial
liver abscesses [1], though other possible sources are
IBD, bacteriaemia, hepatic traumas and suppurative
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appendicitis [2]. Enterobacterales, anaerobes [3] and
Gram+ cocci are the most common pathogens involved
in developing this pathology.
Other possible aetiologies are fungal infection (candida
species) and parasitic one (Entamoeba histolytica, Echi-
nococcus granulosus) [4].
We present the case of a woman affected by microliver
abscesses mimicking metastases after infective colitis
due to Y. enterocolitica apparently with no risk factors,
such as haemochromatosis, thalassemias and chronic
liver disease. The formation of abscesses from Y. entero-
colitica is uncommon and usually consequent to the en-
teric disease, in particular terminal ileitis, mesenteric
adenitis and enterocolitis.
Case presentation
A 79 yr old Caucasian female affected by heart failure
with preserved ejection fraction (HFpEF) and chronic
kidney disease was admitted to the hospital because of
diarrhoea associated with fever and griping abdominal
pain that appeared just a few hours after a meal based
on pasta with meat sauce. The patient took ciprofloxacin
for three days as indicated by the general practitioner
before being admitted to our ward. The patient was
alert, oriented and afebrile; moderate pain in mesogas-
trium and hypogastrium after deep palpation was noted
during the physical examination. Laboratory investiga-
tions (Table 1) revealed an increased WBC count with
neutrophilia, raised reactive C protein (CRP) and faecal
calprotectin.
The abdominal CT scan performed in the Emergency
Department on the day before the admission in our
ward showed thickening of all the colic walls with asso-
ciated hyperdensity of the local adipose tissue and mul-
tiple enlarged mesenteric lymph nodes (Fig. 1).
The patient was thought to be affected by infective
colitis; consequently, clinicians required multiple blood
cultures and stool tests before starting empiric antibiotic
therapy with ciprofloxacin and metronidazole.
Initially, this therapeutic strategy seemed to be effect-
ive; in fact, the patient denied further diarrhoea episodes
and the abdominal pain disappeared. Nevertheless, clini-
cians observed the appearance of a persistent low-grade
fever (37.4–37-6 °C) and the blood tests showed an in-
crease of markers of phlogosis, such as RCP (97.59mg/
L), and WBC count (20.69 * 103/μL).











Total bilirubin 0.69 mg/dL
Alkaline phosphatase 85 U/L
Gamma-glutamyl transpeptidase 59 U/L
GOT/GPT 29/19 U/L
INR 1.1
Activated partial thromboplastin time 33 s
Serum iron 91 μ/L
Transferrin 312 mg/dL
Percentage of saturation of transferrin 33%
Ferritin 258 ng/mL
Faecal calprotectin > 300 mg/Kg
CA 125 55.2 U/mL





Fig. 1 The abdomen TC scan performed at admittance revealed ubiquitous thickening of all the colic walls. ↑ RCP 40.16 mg/L - ↑ ESR 24 mm/h- ↑
WBC 15.85 × 10^3/μL - ↑ Faecal calprotectin > 300mg/
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Clinicians decided to repeat abdominal TC scan with
contrast medium, which revealed multiple hypodense
oval-shaded lesions provided with hyperdense borders
during the arterial phase in the liver (Fig. 2). The ab-
dominal MRI performed the next day confirmed the
presence of these lesions that were hypointense in T1
weighted image and hyperintense in T2 one (Fig. 3),
which were supposed to be the expression of metastatic
disease by the radiologists.
The dosage of neoplastic markers was requested (CA
125, CA 19–9, ferritin, β2-microglobulin, CEA, NSE, α-
fetoprotein), finding slightly increased ferritin levels,
CA-125 and β2-microglobulin (Table 1).
The patient underwent multiple colonoscopies that
showed four benign adenomatous polyps and excluded the
presence of lesions suggestive of neoplasms or IBD; the suc-
cessive histological exam ruled out microscopic colitis.
Total body TC scan with contrast medium was per-
formed searching for the possible primary neoplasm but
resulted negative. Later, 18F-FDG - positron emission
tomography (PET) did not show any lesion with altered
metabolism, which is a possible finding suggestive of
neoplastic disease. PET was preferred to MRI because of
its ability to identify lesions with metabolic activity, such
as metastases.
Because it was not possible to find any possible cancer
with an imaging technique, the next step would have
been the biopsy of one of the lesions to characterize
them and identify the possible primitive site of the ma-
lignancy; unfortunately, the procedure was considered
too dangerous for the patient because of the small size
of the hepatic lesions and the consequent significant
technique difficulty. Meanwhile, clinicians obtained stool
tests and blood cultures (BACTEC 9120) results: while
the firsts were negative, the second ones resulted posi-
tive for Gram-negative bacilli. In agar MacConkey
lactose-negative colonies were observed, successive bio-
chemical identification and antibiogram (MICROSCAN
Walkaway - DADE Behering) identified Y. enterocolitica
sensitive to doxycycline, gentamicin, ceftazidime and
cefixime and resistant to amoxicillin/clavulanate and
cotrimoxazole.
Consequently, specific antibiotic therapy with cefixime
and doxycycline was started, resulting in the fever’s dis-
appearance and the significant reduction of WBC count
and RCP after a week (Table 2).
The patient continued this therapy for one month; ab-
dominal MRI after three weeks (Fig. 4) and two months
(Fig. 5) showed the initial reduction and the subsequent
complete disappearance of the lesions.
Fig. 2 The second TC scan with medium contrast showed multiple small hypodense oval-shaded lesions provided with hyperdense borders
during the arterial phase in the liver, hypodense during the portal and late phase. ↑ RCP 97.59 mg/L - ↑ WBC 20.69 × 10^3/μL
Fig. 3 The abdominal MRI confirmed the presence of the lesions, which were hypointense in T1 weighted image and hyperintense in T2 one
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Finally, blood culture and stool exam were both nega-
tive at two months.
Since microliver abscesses by Y. enterocolitica are
strictly associated with haemochromatosis, clinicians ex-
cluded this pathology by liver MRI and the percentage
of transferrin saturation.
Discussion and conclusion
Multiple liver lesions could often be the expression of ei-
ther hepatic metastases or abscesses or cysts; the differ-
ential diagnosis is not always straightforward.
Imaging techniques sometimes do not manage to be
conclusive for the diagnosis; while cysts have a typical
radiological pattern difficult to be confused, on the other
hand, the distinction between metastases and microliver
abscesses can be intricate, especially when patients have
no previous neoplastic disease. Even the laboratory in-
vestigations could not be diriment: significantly in-
creased white blood count and markers of inflammation
are suggestive of an infective aetiology, but it is possible
to observe borderline levels of these markers, which is
the most common situation, both in hepatic metastases
and microliver abscesses.
Y. enterocolitica is a gram-negative coccobacillus and a
member of Enterobacterales. This bacterium grows in
non-selective agar at a temperature between 25 °C and
37 °C; it ferments sucrose and glucose but not lactose
and is oxidase negative [5].
The yersinioses are zoonotic infections of wild and do-
mestic animals; humans are usually incidental hosts [6].
Infection due to Y. enterocolitica is a cause of entero-
colitis or mesenteric lymphadenitis, a pathology with a
clinical presentation similar to appendicitis. In up to
30% of subjects, post-infectious sequelae, typically glom-
erulonephritis, erythema nodosum or Reiter’s syndrome,
are possible [7].
Most subtypes of Y. enterocolitica lack effective
methods for iron uptake [8]; just a few strains have some
genes for an iron-binding protein called yersiniabactin
[9]. This fact explains why septicemia by Y. enterocolitica
is rare in patients without pathologies characterized by
an iron-overload such as haemochromatosis, thalasse-
mias and chronic liver disease.
The diagnosis of infection by Y. enterocolitca is micro-
biological, isolating bacteria from biological samples,
such as blood and faeces.
The treatment for liver abscesses due to Y. enterocoli-
tica is typically medical, and it is based on antibiotic
therapy with ciprofloxacin, ceftriaxone, cotrimoxazole or
gentamicin for at least three weeks; drainage is possible
only in solitary abscesses.
This clinical case began with common infective colitis
and evolved into a complex one because of multiple rea-
sons that delayed the final diagnosis. First of all, the hep-
atic lesions’ radiological characteristics were suggestive
for metastatic disease; consequently, clinicians spent
time and resources searching for primitive cancer. A bi-
opsy would have quickened the diagnostic process, but
unfortunately, the lesions’ small size made the procedure
too tricky and dangerous. Furthermore, the development
of liver abscesses as a complication of infective colitis by
Y. enterocolitica is rare. As mentioned above, bacteriae-
mia is improbable without systemic pathologies charac-
terized by a condition of iron-overload; since the patient
did not have any risk factor, the presence of microliver










Activated partial thromboplastin time 32 s
INR 1.19
Fig. 4 The MRI performed at three weeks showed the initial reduction of the lesions
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abscesses due to Y. enterocolitica was unexpected, mak-
ing this case rather peculiar.
A possible explanation of the initial absence of fever
and the negativity of the stool tests could be represented
by the ciprofloxacin taken by the patients before hospital
admittance; this therapy could have been partially effect-
ive, but it did not avoid bacteriaemia and the subsequent
formation of microliver abscesses which caused the ap-
pearance of fever and the increase of the markers of
inflammation.
The diagnosis was the result of effective multidisciplin-
ary teamwork between internists, radiologists and
microbiologists.
In this case, we observed how challenging the differen-
tial diagnosis between hepatic metastases and microliver
abscesses could be; furthermore, bacteriaemia by Y.
enterocolitica cannot be excluded in patients with sug-
gestive symptomatology even when there are no risk
factors.
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Fig. 5 The MRI performed at 2 months showed the disappearance of the lesions
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